At iBio, we’re pioneering the next generation of biopharmaceuticals using the Fastpharming®️ System, our proprietary plant-based recombinant protein manufacturing platform.
The speed, safety, and scalability inherent in the FastPharming Technology make it ideal for rapidly advancing promising candidates from concept to clinic, while also enabling “greener” manufacturing. We seek to change the drug development paradigm by reducing the time, costs, and scale-up issues associated with traditional mammalian cell culture production – thus making plant-based manufacturing the preferred choice for high-quality biopharmaceutical development.